loading page

HUMAN ASTROVIRUS VA1 ENCEPHALITIS IN PEDIATRIC CANCER PATIENTS: REPORT OF TWO CASES AND REVIEW OF THE LITERATURE
  • +10
  • Sakshi Bami,
  • Jennifer Hidinger,
  • Arshia Madni ,
  • Virginia Hargest,
  • Stacey Schultz-cherry,
  • Valerie Cortez,
  • Shane Cross,
  • Deborah Ward,
  • Randall Hayden,
  • Jeffrey Rubnitz,
  • Ching-Hon Pui,
  • Raja Khan,
  • Diego Hijano
Sakshi Bami
St Jude Children's Research Hospital

Corresponding Author:[email protected]

Author Profile
Jennifer Hidinger
St Jude Children's Research Hospital
Author Profile
Arshia Madni
St Jude Children's Research Hospital
Author Profile
Virginia Hargest
St Jude Children's Research Hospital
Author Profile
Stacey Schultz-cherry
St Jude Children's Research Hospital
Author Profile
Valerie Cortez
St Jude Children's Research Hospital
Author Profile
Shane Cross
St. Jude Children's Research Hospital
Author Profile
Deborah Ward
St. Jude Children's Research Hospital
Author Profile
Randall Hayden
St Jude Children's Research Hospital
Author Profile
Jeffrey Rubnitz
St. Jude Children's Research Hospital
Author Profile
Ching-Hon Pui
St. Jude Children's Research Hospital
Author Profile
Raja Khan
St. Jude Children's Research Hospital
Author Profile
Diego Hijano
St. Jude Children's Research Hospital
Author Profile

Abstract

Novel human astrovirus (HAstV) strains have been recently shown to cause fatal encephalitis in immunocompromised patients. We report two cases from our institution. A 2-year old female undergoing treatment for acute lymphoblastic leukemia and a 9-year old male with refractory acute myeloid leukemia. Both were found to have HAstV-VA1 in the cerebrospinal fluid (CSF) by metagenomics next generation sequencing (m-NGS) after the initial evaluation did not reveal any etiology. Patient 1 remains alive, in remission, showing gradual neurological improvement after treatment with steroids, intravenous immunoglobulin, ribavirin, nitazoxanide and Peg-INF-alpha 2b. Patient 2 died 7 weeks later while receiving palliative care.